Brucellosis: A rare cause of febrile neutropenia in acute myeloblastic leukemia
No Thumbnail Available
Date
2011
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Brucellosis is a zoonotic disease and endemically seen in the Middle East, Eastern Europe and continental America. Febrile neutropenia related to Brucellosis has been reported only in a few cases. Brucella was cultured from the bone morrow of a 42-year-old woman who was admitted to hospital with symptoms of fever and fatigue and later diagnosed as acute myeloblastic leukemia (AML). The patient was treated for both AML and Brucellosis without any problems and discharged from the hospital after scheduling her follow-up visits. Brucellosis might be considered in the etiology of febrile neutropenia in endemic regions and must be treated effectively to prevent possible morbidity and mortality during or after chemotherapy. © 2010 Springer Science+Business Media, LLC.
Description
Keywords
Adult , Antineoplastic Combined Chemotherapy Protocols , Brucellosis , Cytarabine , Diagnosis, Differential , Female , Humans , Idarubicin , Leukemia, Myeloid, Acute , Neutropenia , Prognosis , Remission Induction , alanine aminotransferase , amphotericin B , bilirubin , caspofungin , cilastatin , ciprofloxacin , cotrimoxazole , cytarabine , doxycycline , gamma glutamyltransferase , gentamicin , idarubicin , imipenem , rifampicin , teicoplanin , acute myeloblastic leukemia , adult , agglutination test , alanine aminotransferase blood level , anamnesis , article , bilirubin blood level , bone marrow biopsy , bone marrow culture , Brucella , brucellosis , case report , drug hypersensitivity , drug substitution , drug withdrawal , fatigue , febrile neutropenia , female , fever , gamma glutamyl transferase blood level , human , human tissue , mucosa inflammation , neutrophil count , priority journal , remission , side effect , symptomatology